Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,743 total articles
Intel is no longer just a laggard catching up. Recent product wins, process progress and improving momentum have shifted the risk-reward profile. This trade idea outlines a long position with specific entry, stop and target, timing across a 180-trading-day horizon, and a balanced view of catalysts and risks.
China Automotive Systems (CAAS) is upgraded to Buy after the company began volume shipments of electric power steering systems to a major European automaker and trades at a sub-0.4 PB and ~3.6 PE. The setup is actionable for a mid-term swing, but the small float and choppy daily volume call for disciplined sizing, limit orders, and a strict stop.
Meta appears to have established a meaningful lead in foundational AI and product-integrated models. This trade targets an asymmetric upside as the market re-rates Meta for sustainable higher monetization per user across ads, commerce, and new AI-driven services. Entry $380.00, target $480.00, stop $330.00 — long term (180 trading days).
Associated Banc-Corp (ASB) looks attractively priced after a stretch of deposit pressure and elevated short activity. At roughly $5.5B market cap, the stock trades at a modest PE of 10.3 and book at parity, pays a 3.2% yield and carries a fresh $100M buyback. Technicals are oversold (RSI ~33) and support a mean-reversion trade into the next earning…
Oscar Health's Investor Day laid out a dramatically larger TAM and revenue roadmap that, if executed smoothly, supports materially higher multiples. The stock trades at $30.68 with a $9.47B market cap and improving earnings revisions. This trade idea buys the path to execution with a clear stop and a take-profit that reflects delivery on the Invest…
Advanced Micro Devices is trading at a $1.02 trillion market cap with clear momentum indicators and accelerating data-center adoption. We lay out a long trade with entry at $624.00, a $800 target and a $560 stop, sized for investors who accept medium risk and want exposure to AI infrastructure growth over the next 180 trading days.
Medtronic has moved from quiet restructuring to visible top-line momentum. With Q1 strength, raised FY27 guidance, accelerating adoption of the Hugo robotic platform and new cardiac offerings, the risk/reward for a mid-term long trade looks attractive. Entry at $91.00, stop $86.00, target $102.00 over ~45 trading days.
Hyperliquid (HYPX) is an early-stage decentralized exchange ecosystem that aims to combine concentrated liquidity, on-chain order routing, and native incentive layers. This trade idea argues for a speculative long entry at $0.75 with a $2.50 target and $0.40 stop based on the potential for platform-specific liquidity growth, token utility expansion…
Spire is a small-cap satellite-data provider trading at a modest market cap and high revenue multiple for a growth-to-profit pivot. If NOAA-related contracts or other government work accelerate in H2, revenue and backlog could re-rate the stock. This trade targets that inflection while keeping a tight stop to limit downside from execution risk.
SK hynix looks positioned to extend recent improvement as DRAM and NAND chips reflate on AI and server demand. This is a tactical long trade sized for a mid-term swing: entry at $95.00, a stop at $82.50, and a target at $120.00. The trade leans on clearer demand signals, expanding high-margin HBM exposure, and an overall memory cycle recovery while…
Archer (ACHR) trades at $5.695 after a 62% drop from its 52-week high. Negative profitability, steep cash burn, and heavy short activity combine with uncertain certification and integration milestones to create a high-risk setup. We favor a tactical short over the next 45 trading days, with a clear entry, stop and target.
Turning Point Brands (TPB) has been punished this year on FDA-related headlines and heavy marketing investments that temporarily compress earnings. The sell-off has pushed technicals into deeply oversold territory while balance-sheet metrics and cash flow remain intact. We upgrade TPB to a buy for a tactical swing trade - the market is now overly c…
TON Strategy Company is a leveraged, asymmetric play on the revival and market adoption of GRAM. For traders willing to accept high volatility and structural uncertainty, a modest long position around $1.20 with a tight stop and a $2.80 target offers a favorable risk-reward if token catalysts materialize over the next 45 trading days.
Sprouts Farmers Market is trading roughly 41% below my fair value estimate of $118. The stock's recent pullback has pushed technicals into oversold territory while fundamentals - solid gross margins, positive new-store vintages and manageable valuation versus future earnings - argue for a rebound. This is a long trade idea with entry $69.50, stop $…
DRDGOLD (DRD) is a niche surface-gold retreatment specialist trading at a modest multiple with a $2.31B market cap and 9.1x PE. With dividend income, improving technicals and rising short interest, the stock offers an asymmetric risk-reward for a long trade over the next 180 trading days as the company moves toward higher production in fiscal 2027.
Hagerty is trading near fresh highs as its Broad Arrow auctions and marketplace execution keep revenue mix diversifying. Strong free cash flow, reasonable price-to-sales and a falling short interest backdrop support a mid‑term long. Trade plan included with entry, stop and target for a 45 trading day horizon.
Surgery Partners (SGRY) looks attractive after a reported Idaho Falls asset divestment that should modestly improve leverage and free up capital. At $15.85, the shares trade below prior peaks, have improving technical momentum, and sit at a valuation that discounts operating leverage and higher rates. This trade targets $20.00 with a $13.50 stop on…
Volaris (VLRS) is a cautious buy at $6.93. The ultra-low-cost carrier is showing operational resilience in traffic and load factors, has completed regulatory aircraft inspections with minimal disruption, and trades at a market cap of roughly $808M. Technicals are neutral-to-bullish and short interest has retreated from earlier peaks. This is a risk…
Circle's regulatory progress, accelerating USDC circulation and improving profitability have combined to create a compelling setup for a swing trade. Market cap is ~$24B, free cash flow is $761.5M, and recent earnings showed continued USDC growth. Technicals show constructive momentum and short interest remains a potential squeeze catalyst. Trade p…
Ormat (ORA) is a capital-intensive but unique provider of 24/7 renewable baseload power. Recent PPAs, a commercial-scale Ormega100 roll-out, and a near-term project pipeline argue for upside from current levels. We upgrade to Buy with a defined entry, stop and target and a long-term (180 trading days) horizon while flagging execution and funding ri…
Intel is no longer just a legacy CPU maker. With a ramp in AI-capable Core Ultra chips, progress in foundry services and a data-center recovery, the stock looks primed for a sustained rerating. Valuation is rich on headline metrics, but improving revenue and renewed investor appetite for semiconductors create a tradeable long with defined risk cont…
Celestica (CLS) sits at the intersection of contract manufacturing and hyperscale AI infrastructure demand. The stock offers exposure to 800G/1.6T networking and AI compute hardware via its Connectivity and Cloud Solutions (CCS) segment, while Advanced Technology Solutions (ATS) diversifies revenue into HealthTech and aerospace. At $356.05 and a $4…
NextEra (NEE) is trading near $79.44 with technicals showing oversold conditions and fundamentals that support a constructive, tactical long. A confirmed 207 MW offtake for AI compute would be a compact but important proof point that could unlock up to 1.4 GW of follow-on opportunities from hyperscalers, accelerating NEER/NEET's growth profile and …
Nano Labs is a beat-up small-cap maker of AI and high-performance computing chips that has been punished by weak revenue and a crypto-related markdown. The company’s strategic BNB reserve, CEO buying, and AI data-center tie-ups give a clear rerating path if execution improves. This is a high-risk swing trade: entry $2.38, target $3.50, stop $1.80, …
Vox Royalty (VOXR) is an asset-light mining royalty and streaming company with a $400.6M market cap, a sub-$6 share price and a low-cost operating footprint. Given a sustained gold market and disciplined capital deployment into royalties/streams, Vox's revenue could plausibly double by 2030. This trade offers asymmetric upside now while keeping ris…
